TRPV1 and bone cancer: For example, prior studies have reported interaction of TRPV1 with NMDA receptors and with lysophosphatidic acid receptors via a PKC-mediated mechanism to mediate peripheral mechanical hypersensitivity in the context of muscle pain and bone cancer pain (Pan et al., 2010; Lee et al., 2012).